Clinical Trials on Neurofibromatosis 1 in New Zealand
Total 730 results
-
University of Alabama at BirminghamCompletedNeurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PNUnited States
-
AlexionRecruiting
-
John Jay High SchoolUnknownNeurofibromatosis Type 1United States
-
NYU Langone HealthCompletedNeurofibromatosis 1 and 2 (NF1 and NF2)United States
-
SpringWorks Therapeutics, Inc.Active, not recruitingPlexiform Neurofibroma | Neurofibromatosis Type 1 (NF1)United States
-
AstraZenecaApproved for marketingNF type1 With Inoperable Plexiform NeurofibromasUnited States
-
University of Alabama at BirminghamNational Cancer Institute (NCI); Children's Hospital of Philadelphia; Washington... and other collaboratorsCompletedNeurofibromatosis Type 1United States, Australia
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Precancerous ConditionUnited States
-
University of Alabama at BirminghamPacific Pediatric Neuro-Oncology Consortium; Array BioPharmaActive, not recruitingNeurofibromatosis Type 1 | Plexiform NeurofibromaUnited States
-
NYU Langone HealthNovartis Pharmaceuticals; The Children's Tumor FoundationCompletedNeurofibromatosis Type IIUnited States
-
NYU Langone HealthBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaTerminatedneurofibromatosis1 (NF1) | Recurrent or Progressive Optic Pathway Gliomas (OPG) | Recurrent or Progressive Low-grade GliomaUnited States
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI); American Lebanese Syrian Associated Charities...RecruitingLow Grade Glioma (LGG) of Brain With BRAF Aberration | High Grade Glioma (HGG) of the Brain With BRAF Aberration | Low Grade Glioma of Brain With Neurofibromatosis Type 1United States
-
Yale UniversityThe Hospital for Sick Children; United States Department of Defense; Connecticut...CompletedChronic Pain | Neurofibromatosis 1United States
-
NFlection Therapeutics, Inc.CompletedNeurofibromatosis 1 | Cutaneous NeurofibromaUnited States
-
National Cancer Institute (NCI)RecruitingNeurofibromatosis Type 1 | Low Grade Glioma | Visual Pathway GliomaUnited States, Canada, Puerto Rico
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Recurrent Childhood Pilocytic Astrocytoma | Recurrent Childhood Visual Pathway GliomaUnited States, Canada, Australia, New Zealand
-
National Cancer Institute (NCI)CompletedNeurofibroma, Plexiform | Neurofibromatosis Type IUnited States, Germany
-
National Cancer Institute (NCI)Active, not recruitingLow Grade Glioma | Recurrent Visual Pathway Glioma | Refractory Visual Pathway Glioma | Recurrent Childhood Pilocytic Astrocytoma | Recurrent Neurofibromatosis Type 1 | Refractory Neurofibromatosis Type 1United States
-
Alvotech Swiss AGCompleted
-
NYU Langone HealthGlaxoSmithKlineCompletedNeurofibromatosis 2 | Vestibular SchwannomaUnited States
-
NYU Langone HealthCompletedNeurofibromatosis Type 2 | Vestibular SchwannomasUnited States
-
NFlection Therapeutics, Inc.CompletedNeurofibromatosis 1 | Cutaneous NeurofibromaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain and Central Nervous System Tumors | Neurofibromatosis Type 1Canada, United States
-
National Cancer Institute (NCI)Children's Oncology GroupActive, not recruitingJuvenile Myelomonocytic Leukemia | Neurofibromatosis Type 1United States
-
National Cancer Institute (NCI)CompletedNeurofibromatosis 1 | Neurofibroma, PlexiformUnited States
-
Diatranz Otsuka LimitedCompleted
-
The Children's Tumor FoundationRecruitingNeurofibromatosis 1 | Neurofibromatosis 2 | SchwannomatosisUnited States
-
Christchurch Clinical Studies Trust LtdMedtronicUnknownType1diabetesNew Zealand
-
University of Alabama at BirminghamCompletedNeurofibromatosis | Plexiform Neurofibromas | NF1United States
-
University of Alabama at BirminghamMedtronic; The Children's Tumor FoundationTerminatedNF1 | Congenital Pseudarthrosis of TibiaUnited States, Australia
-
Dicerna Pharmaceuticals, Inc.WithdrawnAlpha 1-Antitrypsin DeficiencyNew Zealand
-
Arrowhead PharmaceuticalsCompleted
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingNeurofibromatosis 1 | Plexiform Neurofibroma (PN)United States, Canada, France, Italy, Germany, China, United Kingdom, Spain, Japan, Russian Federation, Australia, Poland, Brazil
-
Recursion Pharmaceuticals Inc.RecruitingNeurofibromatosis Type 2United States
-
Northwestern UniversityCompletedNeurofibromatosis Type 1 | Neurofibromatosis Type 2 | Adult Ependymoma | Recurrent Adult Brain Tumor | Acoustic Schwannoma | Adult Anaplastic Meningioma | Adult Grade I Meningioma | Adult Grade II Meningioma | Adult Meningeal Hemangiopericytoma | Adult Papillary MeningiomaUnited States
-
University of Alabama at BirminghamGenentech, Inc.CompletedNeurofibromatosis Type 2 | Progressive Vestibular SchwannomasUnited States
-
University of Alabama at BirminghamMemorial Sloan Kettering Cancer CenterActive, not recruitingNeurofibromatosis 2 | Progressive Vestibular Schwannoma (VS)United States
-
Scott R. Plotkin, MD, PhDTakeda; National Comprehensive Cancer Network; The Children's Tumor FoundationRecruitingEpendymoma | Meningioma | Neurofibromatosis Type 2 | Vestibular Schwannoma | Non-vestibular SchwannomaUnited States
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyCompleted
-
Memorial Sloan Kettering Cancer CenterPfizer; Dana-Farber Cancer Institute; University of Pittsburgh; University of VirginiaCompletedNeurofibromatosis | Meningioma | CNS Cancer | Hemangioblastoma | Intracranial HemangiopericytomaUnited States
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central Nervous System Neoplasm | Recurrent Childhood Brain Stem Glioma | Recurrent Childhood Visual Pathway GliomaUnited States
-
NYU Langone HealthCompletedNeurofibromatosis Type 2 | Meningiomas | Vestibular SchwannomasUnited States
-
Arrowhead PharmaceuticalsRecruitingMyotonic Dystrophy 1New Zealand, Australia
-
Melbourne HealthCompletedType 1 DiabetesAustralia, New Zealand
-
Boston Scientific CorporationCompletedACC/AHA/NASPE Class 1, IIa or IIb IndicationsNetherlands, Italy, United Kingdom, New Zealand
-
Baxalta now part of ShireCompletedAlpha 1-Antitrypsin DeficiencyNew Zealand, Australia
-
Baxalta now part of ShireBaxter Healthcare, Ltd. (New Zealand), Baxter Healthcare Pty. Ltd. (Australia)CompletedAlpha 1-Antitrypsin DeficiencyAustralia, New Zealand
-
Novartis PharmaceuticalsRecruitingGlioblastoma | Astrocytoma | Anaplastic Astrocytoma | Neurofibromatosis Type 1 | Anaplastic Ganglioglioma | Anaplastic Pleomorphic Xanthoastrocytoma | Ganglioglioma | Pleomorphic Xanthoastrocytoma | Diffuse Astrocytoma | Anaplastic Oligodendroglioma | Pilocytic Astrocytoma | Gangliocytoma | Central Neurocytoma | Oligodendroglioma... and other conditionsUnited States, Belgium, Spain, Denmark, Germany, Czechia, Italy, Australia, Russian Federation, France, Netherlands, Japan, Canada, Finland, Sweden, United Kingdom, Argentina, Israel, Brazil
-
Dyne TherapeuticsRecruitingMyotonic Dystrophy Type 1 (DM1)United Kingdom, France, Netherlands, Italy, Germany, New Zealand
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Massachusetts General Hospital; Washington University School of Medicine; Gla... and other collaboratorsCompletedNeurofibromatosis 2 | Vestibular Schwannoma | Acoustic Neuroma | NF2 | Auditory TumorUnited States